Press Releases on August 9, 2023 - EIN Presswire - Press Release Distribution Service

Published on August 9, 2023 - 20:01 GMT

89bio Reports Second Quarter 2023 Financial Results and Provides Corporate Update

– Published data from ENLIVEN Phase 2b trial of pegozafermin in NASH in The New England Journal of Medicine; presented the data in a late-breaker session at the EASL International Liver Congress – – Discussions with regulatory agencies regarding Phase 3 …

Distribution channels: Business & Economy, Technology ...

Published on August 9, 2023 - 20:01 GMT

STRATA Skin Sciences Reports Second Quarter 2023 Revenue

HORSHAM, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 9, 2023 - 20:01 GMT

Xenon Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Last patient enrolled in XEN1101 Phase 2 X-NOVA clinical trial in major depressive disorder with topline data expected in late November to mid-December Continued progress across all XEN1101 Phase 3 epilepsy programs including in X-TOLE2 and X-TOLE3 …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 9, 2023 - 20:01 GMT

Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update

Abstracts for HPN217 and HPN328 accepted for presentations at the International Myeloma Society (IMS) Annual Meeting and the European Society for Medical Oncology (ESMO) in the fall Enrollment for HPN328 (DLL3) ongoing; Phase 2 dose selection expected by …

Distribution channels: Business & Economy, Technology ...

Published on August 9, 2023 - 20:01 GMT

MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results

Advancing enrollment of TAMARACK Phase 2 study in metastatic castration-resistant prostate cancer (mCRPC) under revised protocol Initiating lorigerlimab Phase 2 study in mCRPC patients Achieved $50 million milestone related to Sanofi’s announcement of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 9, 2023 - 20:01 GMT

NV5 Announces Second Quarter Results; Exceeds Analyst Consensus

HOLLYWOOD, Fla., Aug. 09, 2023 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (Nasdaq: NVEE) ("NV5" or the "Company"), a provider of technology, conformity assessment, and consulting solutions, today reported financial results for the second …

Distribution channels: Business & Economy, Technology ...

Published on August 9, 2023 - 20:01 GMT

Merus N.V. Announces Proposed Public Offering of Common Shares

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on August 9, 2023 - 20:01 GMT

PLBY Group Reports Second Quarter 2023 Financial Results

LOS ANGELES, Aug. 09, 2023 (GLOBE NEWSWIRE) -- PLBY Group, Inc. (NASDAQ: PLBY) (“PLBY Group” or the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today …

Distribution channels: Book Publishing Industry, Business & Economy ...

Published on August 9, 2023 - 20:01 GMT

Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress

Q2 2023 revenue was $8.7 million, which represents a 30% increase over Q2 2022 Installed base of Saphyr® systems totaled 281 as of June 30, 2023, which represents a 43% increase over Q2 2022 Sold 7,062 nanochannel array flowcells as of June 30, 2023, which …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...